Rieder, F.; Brenmoehl, J.; Leeb, S.; Schölmerich, J.; Rogler, G.
January 2007
Gut;Jan2007, Vol. 56 Issue 1, p130
Academic Journal
The article investigates wound healing and fibrosis in intestinal disease. Although efforts for the development of anti-inflammatory treatments for patients with inflammatory bowel disease (IBD) have been extensive, treatments for fibrosis and fistulas in IBD are still lacking. Experts recommend for further studies to deepen understanding of the mechanisms responsible for the development of fibrosis in the gastrointestinal mucosa.


Related Articles

  • Description of the registry of patients with ankylosing spondylitis in Turkey: TRASD-IP. Bodur, Hatice; Ataman, Şebnem; Buğdaycı, Derya; Rezvani, Aylin; Nas, Kemal; Uzunca, Kaan; Emlakçıoğlu, Emel; Karatepe, Altınay; Durmuş, Bekir; Sezgin, Melek; Ayhan, Figen; Yazgan, Pelin; Duruöz, Tuncay; Yener, Mahmut; Gürgan, Alev; Kırnap, Mehmet; Çakar, Engin; Altan, Lale; Soydemir, Raikan; Çapkın, Erhan // Rheumatology International;Jan2012, Vol. 32 Issue 1, p169 

    A web-based application patient follow-up program was developed to create a registry of patients with ankylosing spondylitis (AS) by the Turkiye Romatizma Arastirma Savas Dernegi (TRASD) AS Study Group. This study describes the methodological background and patient characteristics. The patient...

  • sulfasalazine.  // Davis's Drug Guide for Nurses, 10th edition;2007, p1091 

    The article presents information on sulfasalazine, an antirheumatic, gastrointestinal anti-inflammatory agent. It is used in the management of inflammatory bowel diseases such as ulcerative colitis, proctitis and proctosigmoiditis. The drug can also be used in the treatment of rheumatoid...

  • PANETH CELLS: THEIR ROLE IN INNATE IMMUNITY AND INFLAMMATIORY DISEASE. Elphick, D. A.; Mahida, Y. R. // Gut;Dec2005, Vol. 54 Issue 12, p1802 

    In this article, we discuss the current understanding of how the intestinal mucosa may exert control over luminal bacteria, and how intestinal inflammation could ensue when this control is lost. We shall review research showing how Paneth cells, and evolutionarily conserved innate immune...

  • LOCALISATION OF EOSINOPHILS TO DIFFERENT SUBSPECIES OF NERVES IN INFLAMMATORY BOWEL DISEASE. Smyth, C. M.; Woods, S.; Thornton, M.; O'Grady, A.; Gleich, G. J.; Murray, F. E.; Costello, R. W. // Gut;Apr2004 Supplement 3, Vol. 53, pA2 

    The role of the eosinophil, which is a common inflammatory cell in inflamed gastrointestinal mucosa in inflammatory bowel disease (IBD) is uncertain. Many of the symptoms of IBD are due to neural dysregulation, including increased mucous production and dysmotilily. Authors hypothesised that an...

  • Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis. Atzeni, Fabiola; Ardizzone, Sandro; Bertani, Luca; Antivalle, Marco; Batticciotto, Alberto; Sarzi-Puttini, Piercarlo; Eliakim, Abraham R. // World Journal of Gastroenterology;5/28/2009, Vol. 15 Issue 20, p2469 

    Inflammatory bowel diseases (IBDs), particularly Crohn's disease (CD) and ulcerative colitis (UC), are associated with a variety of extra-intestinal manifestations (EIMs). About 36% of IBD patients have at least one EIM, which most frequently affect the joints, skin, eyes and the biliary tract....

  • INFLAMMATORY BOWEL DISEASE.  // American Journal of Gastroenterology;Sep2007 Supplement 2, Vol. 102, pS458 

    The article presents abstracts on inflammatory bowel diseases which include an analysis on the therapeutic use of mesalamine-beclomethasone combination, a study on the efficacy of azathioprine in ulcerative colitis and a therapy on ulcerative colitis.

  • Tolerance of Nonsteroidal Antiinflammatory Drugs in Patients With Inflammatory Bowel Disease. Bonner, Gregory F.; Walczak, Michelle; Kitchen, Laurel; Bayona, Manuel // American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p1946 

    OBJECTIVE: We sought to examine whether use of nonsteroidal antiinflammatory drugs (NSAIDs) in an outpatient inflammatory bowel disease (IBD) population is associated with an increased likelihood of active disease. METHODS: We reviewed records of initial outpatient visits of IBD patients to the...

  • Effects of Nonsteroidal Antiinflammatory Drugs on Inflammatory Bowel Disease: A Case-Control Study. Felder, Joseph B.; Korelitz, Burton I.; Rajapakse, Ramona; Schwarz, Samuel; Horatagis, Angelo P.; Gleim, Gilbert // American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p1949 

    OBJECTIVE: The aim of this study was to determine whether a relationship exists between the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and exacerbation or onset of inflammatory bowel disease (IBD). METHODS: Sixty consecutive IBD patients admitted to the hospital were carefully...

  • Higher Expression of Glucocorticoid Receptor in Peripheral Mononuclear Cells in Inflammatory Bowel Disease. Schottelius, Arndt; Wedel, Susanne; Weltrich, Renita; Rohde, Wolfgang; Buttgereit, Frank; Schreiber, Stefan; Lochs, Herbert // American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p1994 

    OBJECTIVE: Glucocorticoids are widely used in the treatment of inflammatory bowel disease (IBD). Up- and down-regulated expression of glucocorticoid receptors (GR) has been reported for different chronic inflammatory diseases. The aim of this study was to investigate the expression of GR and...


Read the Article


Sign out of this library

Other Topics